Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 4 | 2022 | 37 | 1.500 |
Why?
|
| Acute Kidney Injury | 4 | 2020 | 590 | 1.270 |
Why?
|
| Carrier State | 5 | 2020 | 75 | 1.120 |
Why?
|
| Agricultural Workers' Diseases | 3 | 2020 | 12 | 0.910 |
Why?
|
| Nicaragua | 6 | 2024 | 26 | 0.910 |
Why?
|
| Dengue | 2 | 2024 | 82 | 0.900 |
Why?
|
| Travel | 2 | 2024 | 105 | 0.890 |
Why?
|
| Dengue Virus | 1 | 2024 | 94 | 0.850 |
Why?
|
| RNA, Viral | 2 | 2024 | 525 | 0.810 |
Why?
|
| Staphylococcus aureus | 5 | 2020 | 457 | 0.760 |
Why?
|
| Staphylococcal Infections | 5 | 2020 | 550 | 0.750 |
Why?
|
| Nickel | 1 | 2020 | 22 | 0.730 |
Why?
|
| Trace Elements | 1 | 2020 | 24 | 0.730 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2022 | 681 | 0.580 |
Why?
|
| Nasal Cavity | 1 | 2017 | 47 | 0.540 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 220 | 0.470 |
Why?
|
| Dog Diseases | 3 | 2022 | 50 | 0.430 |
Why?
|
| Kidney | 1 | 2017 | 1329 | 0.360 |
Why?
|
| Young Adult | 8 | 2021 | 8627 | 0.310 |
Why?
|
| HIV Infections | 2 | 2017 | 1859 | 0.300 |
Why?
|
| Glomerular Filtration Rate | 2 | 2020 | 470 | 0.280 |
Why?
|
| Nose | 2 | 2017 | 93 | 0.260 |
Why?
|
| Public Health | 3 | 2021 | 236 | 0.240 |
Why?
|
| Cat Diseases | 2 | 2021 | 13 | 0.240 |
Why?
|
| Serogroup | 1 | 2024 | 48 | 0.230 |
Why?
|
| Disease Transmission, Infectious | 2 | 2021 | 83 | 0.230 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 214 | 0.220 |
Why?
|
| Adult | 8 | 2021 | 28363 | 0.220 |
Why?
|
| Houseflies | 1 | 2022 | 2 | 0.210 |
Why?
|
| Muscidae | 1 | 2022 | 2 | 0.210 |
Why?
|
| Cockroaches | 1 | 2022 | 6 | 0.210 |
Why?
|
| Disease Reservoirs | 1 | 2021 | 24 | 0.200 |
Why?
|
| Sports Medicine | 1 | 2021 | 26 | 0.190 |
Why?
|
| Football | 1 | 2021 | 28 | 0.190 |
Why?
|
| Pets | 1 | 2021 | 14 | 0.190 |
Why?
|
| Education, Graduate | 1 | 2011 | 19 | 0.190 |
Why?
|
| Risk Management | 1 | 2021 | 67 | 0.190 |
Why?
|
| Contact Tracing | 1 | 2021 | 56 | 0.190 |
Why?
|
| Students, Public Health | 1 | 2010 | 4 | 0.190 |
Why?
|
| Farmers | 1 | 2020 | 12 | 0.190 |
Why?
|
| Universities | 1 | 2021 | 123 | 0.180 |
Why?
|
| Nails | 1 | 2020 | 17 | 0.180 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2010 | 20 | 0.180 |
Why?
|
| Disaster Planning | 1 | 2011 | 59 | 0.180 |
Why?
|
| Risk Factors | 4 | 2018 | 9603 | 0.180 |
Why?
|
| Endemic Diseases | 1 | 2020 | 49 | 0.180 |
Why?
|
| Humans | 21 | 2024 | 121045 | 0.180 |
Why?
|
| Male | 12 | 2022 | 58908 | 0.180 |
Why?
|
| Botswana | 2 | 2017 | 76 | 0.180 |
Why?
|
| Infection Control | 1 | 2021 | 159 | 0.170 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 232 | 0.170 |
Why?
|
| Occupational Exposure | 1 | 2020 | 128 | 0.170 |
Why?
|
| Students | 1 | 2021 | 248 | 0.170 |
Why?
|
| Biomarkers | 2 | 2018 | 2919 | 0.160 |
Why?
|
| Communicable Disease Control | 1 | 2010 | 137 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 327 | 0.160 |
Why?
|
| Prognosis | 2 | 2018 | 4472 | 0.160 |
Why?
|
| Middle Aged | 5 | 2024 | 25263 | 0.160 |
Why?
|
| Creatinine | 1 | 2020 | 377 | 0.160 |
Why?
|
| Arbovirus Infections | 1 | 2018 | 19 | 0.150 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 59 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2018 | 5854 | 0.150 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 396 | 0.140 |
Why?
|
| Crowding | 1 | 2017 | 9 | 0.140 |
Why?
|
| Atrophy | 1 | 2017 | 221 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 463 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2017 | 178 | 0.140 |
Why?
|
| Female | 10 | 2022 | 63993 | 0.140 |
Why?
|
| Edema | 1 | 2017 | 134 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 231 | 0.140 |
Why?
|
| Dogs | 3 | 2022 | 772 | 0.130 |
Why?
|
| Staphylococcus epidermidis | 1 | 2016 | 40 | 0.130 |
Why?
|
| Fibrosis | 1 | 2017 | 422 | 0.130 |
Why?
|
| Fever | 1 | 2018 | 291 | 0.130 |
Why?
|
| Rural Population | 1 | 2017 | 236 | 0.130 |
Why?
|
| Incidence | 2 | 2021 | 2965 | 0.120 |
Why?
|
| Texas | 5 | 2021 | 3508 | 0.120 |
Why?
|
| Biopsy | 1 | 2017 | 1238 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 274 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3209 | 0.110 |
Why?
|
| Prevalence | 2 | 2017 | 2346 | 0.110 |
Why?
|
| Inflammation | 2 | 2017 | 1396 | 0.110 |
Why?
|
| Disease Progression | 1 | 2018 | 1968 | 0.100 |
Why?
|
| Genetic Variation | 2 | 2016 | 1470 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2055 | 0.100 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 1037 | 0.100 |
Why?
|
| Bacteremia | 1 | 2016 | 406 | 0.100 |
Why?
|
| Cats | 2 | 2021 | 114 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2018 | 3200 | 0.080 |
Why?
|
| Leukocidins | 1 | 2008 | 37 | 0.080 |
Why?
|
| Exotoxins | 1 | 2008 | 44 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1632 | 0.080 |
Why?
|
| Mutation | 1 | 2021 | 5738 | 0.070 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 164 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 368 | 0.070 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 240 | 0.070 |
Why?
|
| Adolescent | 3 | 2018 | 18730 | 0.060 |
Why?
|
| Aged | 3 | 2017 | 18399 | 0.060 |
Why?
|
| Animals | 5 | 2022 | 33472 | 0.050 |
Why?
|
| Paraquat | 1 | 2022 | 12 | 0.050 |
Why?
|
| Agrochemicals | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.050 |
Why?
|
| Insect Control | 1 | 2022 | 13 | 0.050 |
Why?
|
| United States | 3 | 2021 | 10332 | 0.050 |
Why?
|
| Basic Reproduction Number | 1 | 2021 | 1 | 0.050 |
Why?
|
| Athletes | 1 | 2021 | 59 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2021 | 191 | 0.050 |
Why?
|
| Surge Capacity | 1 | 2010 | 9 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2021 | 166 | 0.050 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 66 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 4577 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 349 | 0.040 |
Why?
|
| Communicable Diseases, Imported | 1 | 2018 | 6 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2021 | 445 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2018 | 30 | 0.040 |
Why?
|
| Chikungunya Fever | 1 | 2018 | 23 | 0.040 |
Why?
|
| Infant | 3 | 2018 | 12201 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2020 | 370 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 426 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1265 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2577 | 0.040 |
Why?
|
| Coinfection | 1 | 2018 | 168 | 0.030 |
Why?
|
| Child | 4 | 2020 | 23950 | 0.030 |
Why?
|
| West Nile Fever | 1 | 2018 | 127 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 55 | 0.030 |
Why?
|
| Saccharum | 1 | 2015 | 7 | 0.030 |
Why?
|
| Curriculum | 1 | 2011 | 710 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 44 | 0.030 |
Why?
|
| Sigmodontinae | 1 | 2015 | 42 | 0.030 |
Why?
|
| Zoonoses | 1 | 2015 | 37 | 0.030 |
Why?
|
| Tropical Climate | 1 | 2015 | 47 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2018 | 13708 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1086 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 385 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2015 | 193 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 900 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2018 | 7976 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 746 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 674 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3266 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 4340 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1092 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2015 | 158 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 793 | 0.030 |
Why?
|
| Exome | 1 | 2015 | 1035 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 2534 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2008 | 170 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4196 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 757 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 17432 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6091 | 0.020 |
Why?
|